The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Atozet 10mg/10mg Film-coated tablets

10 mg/10 milligram(s) Film-coated tablet

Merck Sharp & Dohme Ireland (Human Health) LimitedPA1286/060/001

Main Information

Trade NameAtozet 10mg/10mg Film-coated tablets
Active SubstancesEzetimibe
Atorvastatin
Strength10 mg/10 milligram(s)
Dosage FormFilm-coated tablet
Licence HolderMerck Sharp & Dohme Ireland (Human Health) Limited
Licence NumberPA1286/060/001

Group Information

ATC CodeC10BA HMG CoA reductase inhibitors in combination with other lipid modifying agents
C10BA05 atorvastatin and ezetimibe

Status

Authorised/WithdrawnAuthorised
Licence Issued07/11/2014
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back